Organoid revolution (2009)
Hans Clevers and colleagues at the Hubrecht Institute showed that a single intestinal stem cell could grow into a self-organizing organoid, launching a field of personalized disease modeling built on living cells.
Organoids became a standard tool for drug testing and disease research.
They depend on living cells, which standard clinical pathology destroys with chemical preservatives.
The MIT device's central value is that it supplies the living cells organoids require, connecting surgical specimens to personalized medicine.
